Related Videos
More from this user
Related Groups
More on Sciencestage.com
ecancertv  |
(0) (0 Votes)
|
Views: (403) Date: (07-04-10) Time: (00:03:25) |
Description: AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer Lori S. Friedman, Ph.D., director, Cancer Signaling and Translational Oncology, Genentech gives a presentation at the 2009 AACR meeting in Denver on: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer.
Related Documents
Related Wikipedia Results
Related Pubmed Results
Related Nature.com Results
Related Answers.com Results